James P. Chambers

James P. Chambers is a Professor in the Department of Molecular Microbiology and Immunology at the University of Texas at San Antonio (UTSA), within the College of Sciences. His research is centered on host-pathogen interactions, biosensor development, and infectious disease immunology, with a focus on pathogens such as Francisella tularensis, Acinetobacter baumannii, and influenza viruses. He leads the Chambers Lab at UTSA's South Texas Center for Emerging Infectious Diseases (STCEID), where he investigates molecular mechanisms of microbial pathogenesis and immune evasion.

His educational background includes a Ph.D. in Biochemistry from the University of Texas Health Science Center at San Antonio, an M.S. in Chemistry from the University of the Incarnate Word, and a B.S. in Biology from St. Mary's University.

Dr. Chambers' research interests span enzymology, glycoconjugate characterization, nucleic acid-based detection, and biosensor sensing elements. His work integrates microbiology, immunology, and molecular engineering to develop novel diagnostic and therapeutic strategies. He has made significant contributions to understanding how pathogens manipulate host proteins like alkaline phosphatase and dnaK to evade immune responses.

The trend in his recent publications reflects a strong emphasis on emerging infectious diseases, particularly SARS-CoV-2 and chlamydial infections. His articles often explore immune responses, host metabolic factors, and repurposing drugs for antimicrobial use. The research spans virology, bacteriology, immunology, and bioengineering, with a recurring focus on molecular mechanisms and translational applications.

Dr. Chambers has co-authored numerous peer-reviewed articles, primarily in high-impact journals such as Frontiers in Immunology, Journal of Pathogens, and Current Issues in Molecular Biology. While no specific awards are listed, his sustained publication record and leadership in active research suggest recognition in the scientific community.

He mentors students and collaborates extensively with researchers like Dr. Bernard P. Arulanandam. His lab is involved in grant-funded research related to biosensors and emerging infectious diseases, though specific grants are not detailed. The Chambers Lab operates within STCEID, a collaborative research center focused on combating infectious threats through interdisciplinary science.

The lab environment supports advanced research in molecular microbiology and immunology, utilizing techniques in protein biochemistry, immune profiling, and microfluidic systems. Future work appears to focus on the interplay between infection, metabolism, and immunity, particularly in the context of respiratory and systemic pathogens.